Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…
Read More
Johns Hopkins Researchers Discover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression
In a landmark study published in the journal Cell Reports on April 22, investigators at the Johns Hopkins Kimmel Cancer…
Read More
FDA Proposes Permanent Authorization of Rare Pediatric Disease Priority Review Voucher Program to Foster Regulatory Stability
The United States Food and Drug Administration (FDA) is making a significant move to permanently authorize the rare pediatric disease…
Read More
Johns Hopkins Researchers Uncover Liquid Condensate Mechanism Driving Rare Translocation Renal Cell Carcinoma and Potential Therapeutic Pathways
In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
Biogen Acquires Apellis Pharmaceuticals for $5.6 Billion to Bolster Immunology and Rare Disease Portfolio
Biogen, a global biotechnology company renowned for its pioneering work in neuroscience, has announced a significant strategic acquisition of Apellis…
Read More
Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Driven by Fusion Gene Liquid Droplets
In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
A Rare Lunar Impact Creates a Crater the Size of Two Football Fields
The moon, a silent sentinel in our night sky, has revealed a dramatic new feature: a fresh impact crater, estimated…
Read More
New drug cuts seizures by up to 91% in children with rare epilepsy
In a landmark development for pediatric neurology, an international clinical trial has demonstrated that an experimental genetic therapy, zorevunersen, can…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Progression via Liquid Condensates
In a significant advancement for the field of molecular oncology, a collaborative study led by investigators at the Johns Hopkins…
Read More
